American Association for Cancer Research
Browse
- No file added yet -

Document for the supplementary figure legends from Comparison between Urine and Cervical Samples for HPV DNA Detection and Typing in Young Women in Colombia

Download (11.57 kB)
journal contribution
posted on 2023-04-03, 22:12 authored by Alba Lucía Cómbita, Tarik Gheit, Paula González, Devi Puerto, Raúl Hernando Murillo, Luisa Montoya, Alex Vorsters, Severien Van Keer, Pierre Van Damme, Massimo Tommasino, Gustavo Hernández-Suárez, Laura Sánchez, Rolando Herrero, Carolina Wiesner

Document for the supplementary figure legends.

Funding

Colombian Health and Social Protection Ministry

Instituto Nacional de Cancerología

History

ARTICLE ABSTRACT

Urine sampling for HPV DNA detection has been proposed as an effective method for monitoring the impact of HPV vaccination programs; however, conflicting results have been reported. The goal of this study was to evaluate the performance of optimized urine HPV DNA testing in women aged 19 to 25 years. Optimization process included the use of first void urine, immediate mixing of urine with DNA preservative, and the concentration of all HPV DNA, including cell-free DNA fragments. Urine and cervical samples were collected from 535 young women attending cervical screening at health centers from two Colombian cities. HPV DNA detection and genotyping was performed using an HPV type-specific multiplex genotyping assay, which combines multiplex polymerase chain reaction with bead-based Luminex technology. Concordance between HPV DNA detection in urine and cervical samples was determined using kappa statistics and McNemar tests. The accuracy of HPV DNA testing in urine samples was evaluated measuring sensitivity and specificity using as reference the results obtained from cervical samples. Statistical analysis was performed using STATA11.2 software. The findings revealed an overall HPV prevalence of 60.00% in cervical samples and 64.72% in urine samples, HPV-16 being the most frequent HPV type detected in both specimens. Moreover, our results indicate that detection of HPV DNA in first void urine provides similar results to those obtained with cervical samples and can be used to monitor HPV vaccination trials and programs as evidenced by the substantial concordance found for the detection of the four vaccine types. Cancer Prev Res; 9(9); 766–71. ©2016 AACR.

Usage metrics

    Cancer Prevention Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC